C O N M E D Corp (CNMD) Stock Price, Quote & News

Company Profile

CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures in the United States and internationally. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides suppor...

Industry: Medical Devices

Sector: Healthcare

Phone: 727 392 6464

Website: www.conmed.com

Address:

11311 Concept Boulevard, Largo, United States

Estimize Dec. 15 at 1:03 PM

Wall St is expecting 1.32 EPS for $CNMD Q4 [Reporting 01/29 AMC] http://www.estimize.com/intro/cnmd?chart=historical&metric_name=eps&utm_co

0 · Reply

ZacksResearch Dec. 8 at 4:39 PM

$CNMD shares plunged more than 9% following the announcement of its exit from gastroenterology products. Is this a strategic pivot or a red flag? 🚩 📉 Shares have lost 41.5% year-to-date against the industry’s 11% growth 🔍 Focus shifts to higher-margin surgical platforms for better long-term growth Discover the full implications of this move 👉 https://www.zacks.com/stock/news/2801073/conmed-stock-falls-as-it-strategically-exits-gastroenterology-portfolio?cid=sm-stocktwits-2-2801073-body-23828&ADID=SYND_STOCKTWITS_TWEET_2_2801073_BODY_23828

0 · Reply

ZacksResearch Dec. 8 at 3:39 PM

CNMD sell-off might be missing the bigger picture 👀 $CNMD is stepping out of its gastroenterology portfolio to streamline around higher-growth surgical platforms — a move aimed at boosting long-term margins. That’s a classic strategic refocus the market often misprices early. Full take here 👉 https://www.zacks.com/stock/news/2801073/conmed-stock-falls-as-it-strategically-exits-gastroenterology-portfolio?cid=sm-stocktwits-2-2801073-teaser-23821&ADID=SYND_STOCKTWITS_TWEET_2_2801073_TEASER_23821

0 · Reply

JarvisFlow Dec. 8 at 2:38 PM

B of A Securities has adjusted their stance on Conmed ( $CNMD ), setting the rating to Neutral with a target price of 65 → 52.

0 · Reply

ZacksResearch Dec. 4 at 1:37 PM

Time to pounce on $CNMD? The setup looks solid — momentum from its high-margin platforms and a recovering supply chain are working in its favor, even if tariffs and dV5 adoption put some pressure on near-term margins. Full breakdown here 👉 https://www.zacks.com/stock/news/2799391/heres-why-you-should-add-conmed-stock-to-your-portfolio-now?cid=sm-stocktwits-2-2799391-teaser-23362&ADID=SYND_STOCKTWITS_TWEET_2_2799391_TEASER_23362

0 · Reply

ZacksResearch Dec. 4 at 12:37 PM

$CNMD down 35.7% YTD — what's holding back this Zacks Rank #2 (Buy) stock? 📉 ⚠️ Tariff headwinds expected to compress margins by 150 bps in Q4 🤖 AirSeal adoption delayed by Intuitive Surgical’s dV5 integration 🔄 Supply chain recovery progressing but still multi-quarter Discover the full analysis here 👉 https://www.zacks.com/stock/news/2799391/heres-why-you-should-add-conmed-stock-to-your-portfolio-now?cid=sm-stocktwits-2-2799391-body-23361&ADID=SYND_STOCKTWITS_TWEET_2_2799391_BODY_23361

0 · Reply

DaBullRunner Nov. 13 at 8:24 PM

$DRCT you missed my call here AMZE is my next okay 🚨👇🚨👇🚨👇 $NVVE $TNMG $MGRX $CNMD

0 · Reply

DaBullRunner Nov. 13 at 7:55 PM

$CJET another BANGER SDA could get some news any day now from what I’m hearing 🚨🚨🚨 I’m even willing to put some of my COIN TSLA profits into SDA $TNMG $CNMD $CABR $KXIN watching

1 · Reply

lecorb Nov. 13 at 1:09 PM

$CNMD 6-K 2025-11-13 On November 13, 2025, Clearmind Medicine (the “Company”), entered into a definitive securities purchase agreement (the “Securities Purchase Agreement”) with investors for the purchase and sale of (i) 958,222 of the Company’s common shares, no par value (the “Common Shares”), and (ii) pre-funded warrants (the “Pre-Funded Warrants”) to purchase up to 2,984,146 Common Shares, in a registered direct offering (the “Offering”) at a purchase price of $0.20 per Common Share and $0.1999 per Pre-Funded Warrant https://app.quotemedia.com/data/downloadFiling?webmasterId=500&ref=319574045&type=HTML&symbol=CMND&cdn=01dc782b10f09cdd23fb273fa8e031fb&companyName=Clearmind+Medicine+Inc.&formType=6-K&formDescription=Report+of+foreign+private+issuer+pursuant+to+Rule+13a-16+or+15d-16+under+the+Securities+Exchange+Act+of+1934&dateFiled=2025-11-13

0 · Reply

SuperGreenToday Nov. 6 at 10:26 PM

$CNMD Share Price: $44.20 Contract Selected: Feb 20, 2026 $50 Calls Buy Zone: $1.91 – $2.36 Target Zone: $3.14 – $3.84 Potential Upside: 55% ROI Time to Expiration: 105 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

CONMED Corporation Announces Strategic Exit from Gastroenterology Product Lines

Nov 5, 2025, 10:11 PM EST - 7 weeks ago

CONMED Corporation (CNMD) Q3 2025 Earnings Call Transcript

Nov 5, 2025, 4:05 PM EST - 7 weeks ago

CONMED Corporation Announces Third Quarter 2025 Financial Results

Oct 2, 2025, 4:05 PM EDT - 2 months ago

CONMED Corporation to Announce Third Quarter 2025 Financial Results on November 5, 2025

Sep 9, 2025, 4:05 PM EDT - 3 months ago

CONMED Corporation Adds Kim Kelderman to its Board of Directors

Aug 8, 2025, 7:00 AM EDT - 4 months ago

CONMED Corporation Announces Quarterly Cash Dividend

Jul 30, 2025, 10:48 PM EDT - 5 months ago

CONMED Corporation (CNMD) Q2 2025 Earnings Call Transcript

Jul 30, 2025, 4:05 PM EDT - 5 months ago

CONMED Corporation Announces Second Quarter 2025 Financial Results

Jul 7, 2025, 5:00 PM EDT - 6 months ago

Martha Aronson to Step Down from CONMED Board of Directors Following Appointment as President and Chief Executive Officer of Merit Medical Systems, Inc.

Jul 2, 2025, 4:05 PM EDT - 6 months ago

CONMED Corporation to Announce Second Quarter 2025 Financial Results on July 30, 2025

May 21, 2025, 7:03 AM EDT - 7 months ago

CONMED Corporation Appoints LaVerne Council as Chair of the Board of Directors

Apr 30, 2025, 9:52 PM EDT - 8 months ago

CONMED Corporation (CNMD) Q1 2025 Earnings Call Transcript

Apr 30, 2025, 4:05 PM EDT - 8 months ago

CONMED Corporation Announces First Quarter 2025 Financial Results

Apr 2, 2025, 4:05 PM EDT - 9 months ago

CONMED Corporation to Announce First Quarter 2025 Financial Results on April 30, 2025

Feb 25, 2025, 7:03 AM EST - 10 months ago

CONMED Corporation Adds Mark Kaye to its Board of Directors

Feb 6, 2025, 6:57 AM EST - 11 months ago

These Analysts Slash Their Forecasts On Conmed After Q4 Results

Feb 5, 2025, 7:05 PM EST - 11 months ago

CONMED Corporation (CNMD) Q4 2024 Earnings Call Transcript

Feb 5, 2025, 4:05 PM EST - 11 months ago

CONMED Corporation Announces Fourth Quarter and Full-Year 2024 Financial Results

Jan 6, 2025, 4:16 PM EST - 1 year ago

CONMED Corporation to Announce Fourth Quarter 2024 Financial Results on February 5, 2025

Jan 2, 2025, 4:05 PM EST - 1 year ago

CONMED Corporation to Present at the J.P. Morgan Healthcare Conference

Nov 25, 2024, 8:29 AM EST - 1 year ago

Top 3 Health Care Stocks That May Dip This Month

BFLY MDGL

Nov 18, 2024, 4:05 PM EST - 1 year ago

CONMED Corporation to Participate in a Fireside Chat at the Piper Sandler Healthcare Conference

Nov 4, 2024, 4:05 PM EST - 1 year ago

CONMED Corporation to Participate in Fireside Chats at Two Investor Conferences on November 19-20

Oct 30, 2024, 9:21 PM EDT - 1 year ago

CONMED Corporation (CNMD) Q3 2024 Earnings Call Transcript

Oct 30, 2024, 4:05 PM EDT - 1 year ago

CONMED Corporation Announces Third Quarter 2024 Financial Results

Oct 30, 2024, 4:02 PM EDT - 1 year ago

CONMED Corporation Announces Leadership Succession

Oct 4, 2024, 8:00 AM EDT - 1 year ago

CONMED Corporation Announces Preliminary Third Quarter Financial Information

Sep 12, 2024, 11:21 AM EDT - 1 year ago

Carpal Tunnel Release Systems Market Forecast Report 2024-2030, Featuring Profiles of Arthrex, Conmed, Innomed, MicroAire Surgical Instruments, Resurgens Orthopaedics, S2S Surgical and Trice Medical

Sep 3, 2024, 4:05 PM EDT - 1 year ago

CONMED Corporation to Participate in a Virtual Fireside Chat at the CL King Best Ideas Conference

Aug 19, 2024, 4:05 PM EDT - 1 year ago

CONMED Corporation to Participate in a Fireside Chat at the Wells Fargo Healthcare Conference

Jul 31, 2024, 10:33 PM EDT - 1 year ago

CONMED Corporation (CNMD) Q2 2024 Earnings Call Transcript

Jul 31, 2024, 4:05 PM EDT - 1 year ago

CONMED Corporation Announces Second Quarter 2024 Financial Results

Jul 8, 2024, 4:30 PM EDT - 1 year ago

CONMED Corporation to Announce Second Quarter 2024 Financial Results on July 31, 2024

Jun 21, 2024, 2:49 PM EDT - 1 year ago

AirSeal Concerns Have Let Too Much Air Out Of Conmed's Valuation

May 23, 2024, 4:05 PM EDT - 1 year ago

CONMED Corporation to Participate in a Fireside Chat at the Jefferies Global Healthcare Conference

May 1, 2024, 4:05 PM EDT - 1 year ago

CONMED Corporation to Present at the BofA Securities Healthcare Conference

Apr 25, 2024, 1:16 AM EDT - 1 year ago

CONMED Corporation (CNMD) Q1 2024 Earnings Call Transcript

Apr 24, 2024, 4:05 PM EDT - 1 year ago

CONMED Corporation Promotes Patrick Beyer to Chief Operating Officer

Apr 24, 2024, 4:03 PM EDT - 1 year ago

CONMED Corporation Announces First Quarter 2024 Financial Results

Apr 2, 2024, 4:05 PM EDT - 1 year ago

CONMED Corporation to Announce First Quarter 2024 Financial Results on April 24, 2024

Jan 31, 2024, 9:17 PM EST - 2 years ago

CONMED Corporation (CNMD) Q4 2023 Earnings Call Transcript

Jan 31, 2024, 4:05 PM EST - 2 years ago

CONMED Corporation Announces Fourth Quarter and Full-Year 2023 Financial Results

Jan 3, 2024, 4:05 PM EST - 2 years ago

CONMED Corporation to Announce Fourth Quarter 2023 Financial Results on January 31, 2024

Oct 31, 2023, 4:05 PM EDT - 2 years ago

CONMED Corporation to Participate in Fireside Chats at Two Investor Conferences on November 14-15

Oct 28, 2023, 4:42 AM EDT - 2 years ago

Conmed: Sector Derating And A New Competitive Threat Shouldn't Overshadow A Solid Core Business

Oct 25, 2023, 8:18 PM EDT - 2 years ago

CONMED Corporation (CNMD) Q3 2023 Earnings Call Transcript

Oct 25, 2023, 4:05 PM EDT - 2 years ago

CONMED Corporation Announces Third Quarter 2023 Financial Results

Oct 4, 2023, 4:05 PM EDT - 2 years ago

CONMED Corporation to Announce Third Quarter 2023 Financial Results on October 25, 2023

Jul 26, 2023, 11:03 PM EDT - 2 years ago

CONMED Corporation (CNMD) Q2 2023 Earnings Call Transcript

Jul 26, 2023, 4:05 PM EDT - 2 years ago

CONMED Corporation Announces Second Quarter 2023 Financial Results

Estimize Dec. 15 at 1:03 PM

Wall St is expecting 1.32 EPS for $CNMD Q4 [Reporting 01/29 AMC] http://www.estimize.com/intro/cnmd?chart=historical&metric_name=eps&utm_co

0 · Reply

ZacksResearch Dec. 8 at 4:39 PM

0 · Reply

ZacksResearch Dec. 8 at 3:39 PM

0 · Reply

JarvisFlow Dec. 8 at 2:38 PM

B of A Securities has adjusted their stance on Conmed ( $CNMD ), setting the rating to Neutral with a target price of 65 → 52.

0 · Reply

ZacksResearch Dec. 4 at 1:37 PM

0 · Reply

ZacksResearch Dec. 4 at 12:37 PM

0 · Reply

DaBullRunner Nov. 13 at 8:24 PM

$DRCT you missed my call here AMZE is my next okay 🚨👇🚨👇🚨👇 $NVVE $TNMG $MGRX $CNMD

0 · Reply

DaBullRunner Nov. 13 at 7:55 PM

$CJET another BANGER SDA could get some news any day now from what I’m hearing 🚨🚨🚨 I’m even willing to put some of my COIN TSLA profits into SDA $TNMG $CNMD $CABR $KXIN watching

1 · Reply

lecorb Nov. 13 at 1:09 PM

0 · Reply

SuperGreenToday Nov. 6 at 10:26 PM

0 · Reply

JarvisFlow Nov. 6 at 10:16 PM

JP Morgan updates rating for Conmed ( $CNMD ) to Neutral, target set at 58 → 52.

0 · Reply

ZacksResearch Nov. 6 at 7:48 PM

$CNMD beats estimates, but what's the real story behind its Q3 results? 🤔 📊 Adjusted EPS of $1.08 beat by 2.9%, yet GAAP EPS fell from $1.57 to 9 cents YoY 🔪 Strong growth in General & Orthopedic Surgery lines, but gross margin contracted by 736 bps 🏥 International revenues surged 7.8% on a reported basis and 6.8% at constant exchange rates Discover the full earnings breakdown here 👉 https://www.zacks.com/stock/news/2787133/conmed-q3-earnings-and-revenues-beat-estimates-margins-contract?cid=sm-stocktwits-2-2787133-body-19962&ADID=SYND_STOCKTWITS_TWEET_2_2787133_BODY_19962

0 · Reply

ZacksResearch Nov. 6 at 6:48 PM

$CNMD beats Q3 expectations — but margin pressure clouds the win. Strong performance in surgery segments lifted both earnings and revenue above estimates, yet contracting gross and operating margins raise fresh concerns. Full earnings recap here 👉 https://www.zacks.com/stock/news/2787133/conmed-q3-earnings-and-revenues-beat-estimates-margins-contract?cid=sm-stocktwits-2-2787133-teaser-19939&ADID=SYND_STOCKTWITS_TWEET_2_2787133_TEASER_19939

0 · Reply

JarvisFlow Nov. 6 at 4:10 PM

Piper Sandler has adjusted their stance on Conmed ( $CNMD ), setting the rating to Overweight with a target price of 68 → 55.

0 · Reply

JarvisFlow Nov. 6 at 3:45 PM

Wells Fargo has adjusted their stance on Conmed ( $CNMD ), setting the rating to Equal-Weight with a target price of 57 → 47.

0 · Reply

IN0V8 Nov. 6 at 3:21 PM

$CNMD Buy JP Morgan cuts target price to $52 from $58 Piper Sandler cuts target price to $55 from $68

0 · Reply

Estimize Nov. 5 at 4:00 PM

$CNMD reports after the close, Estimize Consensus +0.07 EPS and +0.29M Revs compared to WS http://www.estimize.com/cnmd/fq3-2025?utm_conten

0 · Reply

Estimize Oct. 28 at 11:57 AM

Wall St is expecting 1.05 EPS for $CNMD Q3 [Reporting 11/05 AMC] http://www.estimize.com/intro/cnmd?chart=historical&metric_name=eps&utm_co

0 · Reply

BEATOFtheMARKET Oct. 9 at 11:19 PM

9/26/25 list results $CNM $CNMD $CNNE 🔥 Cycle Trading Signal plugged into AI 🔥 list

0 · Reply

lecorb Sep. 22 at 1:26 PM

$CNMD F-1 Wait! The information in this prospectus is not complete and may be changed. The selling shareholders may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This preliminary prospectus is not an offer to sell these securities and we are not soliciting an offer to buy these securities in any state or jurisdiction where the offer or sale is not permitted. https://app.quotemedia.com/data/downloadFiling?webmasterId=500&ref=319460901&type=HTML&symbol=CMND&cdn=a429fd35d64a0bcd9328e07ad7190fa6&companyName=Clearmind+Medicine+Inc.&formType=F-1&formDescription=Registration+statement+for+securities+of+certain+foreign+private+issuers&dateFiled=2025-09-19

0 · Reply

Brandonchw Sep. 17 at 3:08 PM

$CNMD I would like to wait under 50

0 · Reply

Brandonchw Sep. 17 at 3:07 PM

$CNMD many robotic surgeries are using their products, e.g airseal, what do you guys think

0 · Reply

Market Cap	1.23B
Revenue (ttm)	1.31B
Net Income (ttm)	132.42M
EPS (ttm)	N/A
PE Ratio	8.86
Forward PE	8.91
Profit Margin	10.13%
Debt to Equity Ratio	0.85

Volume	149,900
Avg Vol	532,554
Day's Range	N/A - N/A
Shares Out	30.97M
Stochastic %K	61%
Beta	0.98
Analysts	Sell
Price Target	$48.40